NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hybrigenics SA (EPA: ALHYG)

 
ALHYG Technical Analysis
5
As on 1st Nov 2017 ALHYG Share Price closed @ 0.56 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.75 & Strong Sell for SHORT-TERM with Stoploss of 0.59 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ALHYG Share Price

Open 0.57 Change Price %
High 0.57 1 Day -0.01 -1.75
Low 0.56 1 Week 0.00 0.00
Close 0.56 1 Month -0.05 -8.20
Volume 32379 1 Year -0.21 -27.27
52 Week High 1.04 | 52 Week Low 0.52
 
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
BRS 12.00 0.00%
VK 4.72 0.43%
ALALO 0.04 0.00%
CS 26.31 1.47%
TEC 67.40 0.40%
ACA 14.98 0.00%
ALAUP 0.20 -13.04%
 
EPA France Top Gainers Stocks
MLFCI 0.31 34.78%
AVT 0.19 26.67%
AVT 0.19 26.67%
AVT 0.19 26.67%
AVT 0.19 26.67%
ALFRE 1.81 25.69%
CFI 2.01 20.36%
CFI 2.01 20.36%
CFI 2.01 20.36%
CFI 2.01 20.36%
 
EPA France Top Losers Stocks
MLROU 6.37 -34.19%
MLLEA 0.61 -23.75%
ALAUP 0.20 -13.04%
OXI 0.08 -11.11%
OXI 0.08 -11.11%
MLFXO 3.79 -9.98%
TONN 1.20 -9.77%
ALCLS 26.88 -9.22%
RUSAL 10.00 -9.09%
ALEUP 0.20 -9.09%
 
 
ALHYG
Daily Charts
ALHYG
Intraday Charts
Whats New @
Bazaartrend
ALHYG
Free Analysis
 
ALHYG Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE0.57
RESISTANCE0.57
SUPPORT0.55
SUPPORT0.55
SUPPORT0.00
SUPPORT0.00
 
ALHYG Target for Month October
4th UP TARGET0.73
3rd UP TARGET0.68
2nd UP TARGET0.64
1st UP TARGET0.61
1st DOWN TARGET0.51
2nd DOWN TARGET0.48
3rd DOWN TARGET0.44
4th DOWN TARGET0.39
 
ALHYG Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
ALHYG Target for Year 2020
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
ALHYG Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ALHYG Address
ALHYG
3-5 impasse Reille
Paris, 75014
France
Phone: 33 1 58 10 38 00
Fax: 33 1 58 10 38 49
 
ALHYG Latest News
 
Your Comments and Response on Hybrigenics SA
 
ALHYG Business Profile
Hybrigenics S.A., a bio-pharmaceutical company, focuses on the research and development of new targets and therapies against proliferative cancerous or non-cancerous diseases. Its development program is based on inecalcitol, a vitamin D receptor agonist active by oral administration, which is in clinical trial for the treatment of moderate-to-severe psoriasis, as well as planned to be tested in chronic lymphocytic leukemia patients. Oral inecalcitol is intended for the first-line treatment of metastastic castrate-resistant prostate cancer in combination with Taxotere, which is the chemotherapeutic treatment for this indication. The company has research collaboration with Servier on deubiquitinating enzymes and their inhibitors in oncology, neurology, psychiatry, rheumatology, ophthalmology, diabetes, and cardiovascular diseases. It also focuses on the research of ubiquitin-specific proteases by exploring other areas of particular relevance, such as inflammation and virology. The company, through its subsidiary, Hybrigenics Services SAS, provides Yeast Two-Hybrid (Y2H) and related services to identify, validate, and inhibit protein interactions for researchers in the areas of life sciences, using its Y2H screening platform, bioinformatics tools and database, and chemical library and chemical screening platform. Hybrigenics S.A. was founded in 1997 and is headquartered in Paris, France.
 
2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service